{"id":"https://openalex.org/W4417536882","doi":"https://doi.org/10.31351/vol34iss4pp76-84","title":"Evaluation of Antipsoriatic Effect of Ivermectin in Animal model of Psoriasis","display_name":"Evaluation of Antipsoriatic Effect of Ivermectin in Animal model of Psoriasis","publication_year":2025,"publication_date":"2025-12-20","ids":{"openalex":"https://openalex.org/W4417536882","doi":"https://doi.org/10.31351/vol34iss4pp76-84"},"language":"en","primary_location":{"id":"doi:10.31351/vol34iss4pp76-84","doi":"https://doi.org/10.31351/vol34iss4pp76-84","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol34iss4pp76-84","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/3566/1555","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/3566/1555","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ahmed Salim Mahmood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405264270","display_name":"Al-Ameen University","ror":"https://ror.org/01ew3xj77","country_code":"IQ","type":"education","lineage":["https://openalex.org/I4405264270"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Ahmed Salim Mahmood","raw_affiliation_strings":["College of Pharmacy, Al-Ameen University College, Baghdad, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, Al-Ameen University College, Baghdad, Iraq","institution_ids":["https://openalex.org/I4405264270"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zeena Ayad Hussein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56409017","display_name":"Nahrain University","ror":"https://ror.org/05v2p9075","country_code":"IQ","type":"education","lineage":["https://openalex.org/I56409017"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Zeena Ayad Hussein","raw_affiliation_strings":["Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq","institution_ids":["https://openalex.org/I56409017"]}]},{"author_position":"last","author":{"id":null,"display_name":"Nabaa Mohammed Ibrahim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135120706","display_name":"University of Baghdad","ror":"https://ror.org/007f1da21","country_code":"IQ","type":"education","lineage":["https://openalex.org/I135120706"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Nabaa Mohammed Ibrahim","raw_affiliation_strings":["Department of Pharmacognosy, College of Pharmacy, University of Baghdad, Baghdad, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacognosy, College of Pharmacy, University of Baghdad, Baghdad, Iraq","institution_ids":["https://openalex.org/I135120706"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":250000,"currency":"IQD","value_usd":null},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.32582638,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"4","first_page":"76","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ivermectin","display_name":"ivermectin","score":0.996999979019165},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/imiquimod-induced-psoriasis","display_name":"imiquimod-induced psoriasis","score":0.8970000147819519},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8309999704360962},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.9679999947547913},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.996999979019165},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.7689999938011169},{"id":"https://openalex.org/keywords/pasi","display_name":"PASI","score":0.6200000047683716},{"id":"https://openalex.org/keywords/skin-histopathology","display_name":"skin histopathology","score":0.7519999742507935},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.4230000078678131},{"id":"https://openalex.org/keywords/topical-administration","display_name":"topical administration","score":0.35600000619888306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8855000138282776},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.882099986076355},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.7271000146865845},{"id":"https://openalex.org/C2779112978","wikidata":"https://www.wikidata.org/wiki/Q423417","display_name":"Imiquimod","level":2,"score":0.7161999940872192},{"id":"https://openalex.org/C2777499811","wikidata":"https://www.wikidata.org/wiki/Q415178","display_name":"Ivermectin","level":2,"score":0.6406000256538391},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.608299970626831},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5284000039100647},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.5131000280380249},{"id":"https://openalex.org/C2780727990","wikidata":"https://www.wikidata.org/wiki/Q1137321","display_name":"Onchocerciasis","level":2,"score":0.47620001435279846},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.43209999799728394},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.41200000047683716},{"id":"https://openalex.org/C2776390293","wikidata":"https://www.wikidata.org/wiki/Q2035485","display_name":"Subcutaneous injection","level":2,"score":0.40310001373291016},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3869999945163727},{"id":"https://openalex.org/C2778117688","wikidata":"https://www.wikidata.org/wiki/Q264024","display_name":"Animal model","level":2,"score":0.3709000051021576},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3330000042915344},{"id":"https://openalex.org/C2780159080","wikidata":"https://www.wikidata.org/wiki/Q1400536","display_name":"Intraperitoneal injection","level":2,"score":0.3133000135421753},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.3075000047683716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.296099990606308},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.2800000011920929},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.2799000144004822},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.2793000042438507},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.27889999747276306},{"id":"https://openalex.org/C99476002","wikidata":"https://www.wikidata.org/wiki/Q42297","display_name":"Analysis of variance","level":2,"score":0.26910001039505005},{"id":"https://openalex.org/C2777789703","wikidata":"https://www.wikidata.org/wiki/Q192102","display_name":"Skin cancer","level":3,"score":0.26759999990463257},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2667999863624573},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.262800008058548},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.2614000141620636},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2581000030040741}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.31351/vol34iss4pp76-84","doi":"https://doi.org/10.31351/vol34iss4pp76-84","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol34iss4pp76-84","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/3566/1555","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:b3ea085de45741c4817d2245a8df9872","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b3ea085de45741c4817d2245a8df9872","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences, Vol 34, Iss 4 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.31351/vol34iss4pp76-84","doi":"https://doi.org/10.31351/vol34iss4pp76-84","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol34iss4pp76-84","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/3566/1555","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4417536882.pdf","grobid_xml":"https://content.openalex.org/works/W4417536882.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Ivermectin":[0],"(IVR)":[1],"is":[2,25,37,169,187],"widely":[3],"used":[4,26,67,87],"for":[5,120,127,253],"the":[6,28,59,133,138,147,166,200,204,211,221,236,260,287,293],"treatment":[7,29],"of":[8,30,62,117,132,144,155,197,239,262,289,295],"onchocerciasis":[9],"and":[10,24,34,47,55,82,160,184,214,264,275],"other":[11],"nematode":[12],"infections":[13],".Recent":[14],"studies":[15],"have":[16],"reported":[17],"that":[18],"IVR":[19,63,188,198,234,274],"has":[20],"an":[21,50,68],"anti-inflammatory":[22],"effect":[23,61],"in":[27,44,64,73,88,105,177,266,292],"allergic":[31],"asthma,":[32],"dermatitis,":[33],"arthritis.":[35],"Psoriasis":[36,205],"a":[38,279],"chronic":[39],"immune-mediated":[40],"inflammatory":[41],"skin":[42,240,268],"disease":[43,179],"which":[45],"IL-17":[46,263],"VEGF":[48,265],"play":[49],"important":[51],"role":[52],"as":[53,162],"pro-inflammatory":[54],"angiogenic":[56],"mediators.To":[57],"evaluate":[58],"therapeutic":[60],"psoriasis,":[65],"we":[66],"imiquimod":[69],"(IMQ)-induced":[70],"psoriasis":[71,254,296],"model":[72],"rats.":[74],"Twenty-four":[75],"male":[76],"wister-albino":[77],"rats,":[78,201],"age":[79],"3-4":[80],"monthe":[81],"weighing":[83],"170-200":[84],"g":[85],"were":[86,92,125,270],"this":[89,290,298],"experiment.":[90],"They":[91],"assigned":[93],"at":[94],"random":[95],"into":[96],"four":[97,140],"groups,":[98],"each":[99,106],"group":[100,107,149,173,186,190,224,250,282],"include":[101],"6":[102],"animals.":[103],"Rats":[104],"(except":[108],"normal":[109,156],"control":[110,164,223,281],"group)":[111],"are":[112],"topically":[113],"administered":[114],"62.5":[115],"mg":[116],"IMQ":[118,145],"cream":[119],"10":[121],"days,":[122],"then":[123],"they":[124],"treated":[126,150,172,189,249],"12":[128],"days":[129],"with":[130,151,228,242],"one":[131,168],"following":[134],"drugs":[135],"starting":[136],"from":[137],"day":[139],"after":[141],"first":[142,148],"application":[143],"cream:":[146],"subcutaneous":[152],"(SC)":[153],"injection":[154],"saline":[157],"once":[158],"daily":[159],"consider":[161],"positive":[163,222,280],"group;":[165],"second":[167],"Methotrexate":[170],"(MTX)":[171],"using":[174],"conventional":[175],"dose":[176],"autoimmune":[178],"(1.0":[180],"mg/kg/week,":[181],"intraperitoneal":[182],"injection);":[183],"last":[185],"(0.5":[191],"mg/kg/day,":[192],"SC":[193],"injection).":[194],"Subcutaneous":[195],"administration":[196],"to":[199,220,247,258,278],"significantly":[202,271],"minimize":[203],"Area":[206],"Severity":[207],"index":[208],"(PASI)":[209],"regarding":[210],"thickness,":[212],"scaling":[213],"erythema":[215],"(3.00":[216],"\u00b1":[217,226],"2.19)":[218],"comparing":[219,246],"(6.83":[225],"1.16)":[227],"p":[229],"value":[230],"<":[231,284],"0.05.":[232],"Furthermore,":[233],"attenuate":[235],"histopathological":[237],"changes":[238],"lesion":[241,269],"no":[243],"significant":[244],"differences":[245],"MTX":[248,276],"(standard":[251],"drug":[252,291],"treatment).":[255],"In":[256],"addition":[257],"that,":[259],"level":[261],"psoriatic":[267],"reduced":[272],"by":[273,297],"compared":[277],"(p":[283],"0.05),":[285],"suggesting":[286],"ability":[288],"alleviation":[294],"mechanism.":[299]},"counts_by_year":[],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2025-12-21T00:00:00"}